ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-01

AUTHORS

Deepak Thomas, Robert P. Giugliano

ABSTRACT

Unfractionated heparin (UFH) for 48 h has been the traditional standard anticoagulant with fibrinolytics. The Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction (ExTRACT)-Thrombolysis in Myocardial Infarction (TIMI) 25 trial prospectively studied the usefulness of enoxaparin and found that in patients treated with fibrinolysis, enoxaparin administered throughout the index hospitalization was superior to the standard 48-h UFH infusion. However, enoxaparin increased major bleeding. The data from this large trial were further analyzed across various subgroups and these results support the use of enoxaparin in a broad range of patients. The ExTRACT-TIMI 25 trial employed a novel dosing regimen for enoxaparin adjusted for age and renal function, which was designed to minimize bleeding risk while maintaining the beneficial effects of enoxaparin. Based on the evidence from this trial, the 2007 ST-segment elevation myocardial infarction guidelines now preferentially recommend enoxaparin to be administered throughout the index hospitalization as per the dosing regimen used in ExTRACT-TIMI 25 in most patients treated with fibrinolytic therapy. More... »

PAGES

1-10

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-008-0284-0

DOI

http://dx.doi.org/10.1007/s11239-008-0284-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014406797

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18931978


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enoxaparin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibrinolytic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heparin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recurrence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombolytic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ticlopidine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "Department of Nuclear Cardiology, Brigham and Women\u2019s Hospital, 75 Francis Street, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thomas", 
        "givenName": "Deepak", 
        "id": "sg:person.0650361070.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650361070.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "TIMI Study Group, Cardiovascular Division, Brigham and Women\u2019s Hospital, 75 Francis Street, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giugliano", 
        "givenName": "Robert P.", 
        "id": "sg:person.0702207604.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702207604.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.jacc.2007.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000412980"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.106.179918", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000630307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehm210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000964266"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehm224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004392967"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2006.12.049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005322302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000013402.34759.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005846812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2004.08.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009758285"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjmed.2007.08.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010042911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.105.595397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010410408"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.105.551143", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010580667"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000097559.09335.4a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011300096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000081659.72985.a8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011377809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000050144.67910.13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013388391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000142047.28024.f2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015585450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2007.07.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017729419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2006.06.036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019296115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.102.17.2031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020744727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020761305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(03)00163-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022620585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(03)00163-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022620585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(01)05775-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025610328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.106.679548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027489511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehm081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028799784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(02)07588-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029951364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2007.01.093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033029785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.107.182616", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035207018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2007.01.092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035723507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/hc3101.093866", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040424701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.103.18.2310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040443584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.100.10.1134", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041879155"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehm179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045265604"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-0591-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045412171", 
          "https://doi.org/10.1007/s00392-0591-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-0591-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045412171", 
          "https://doi.org/10.1007/s00392-0591-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2004.05.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049874485"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000180580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051087304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(02)07595-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051789238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(04)01110-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054657813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/euhj.2001.2940", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057075086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-130-6-199903160-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073703194"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-01", 
    "datePublishedReg": "2009-01-01", 
    "description": "Unfractionated heparin (UFH) for 48 h has been the traditional standard anticoagulant with fibrinolytics. The Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction (ExTRACT)-Thrombolysis in Myocardial Infarction (TIMI) 25 trial prospectively studied the usefulness of enoxaparin and found that in patients treated with fibrinolysis, enoxaparin administered throughout the index hospitalization was superior to the standard 48-h UFH infusion. However, enoxaparin increased major bleeding. The data from this large trial were further analyzed across various subgroups and these results support the use of enoxaparin in a broad range of patients. The ExTRACT-TIMI 25 trial employed a novel dosing regimen for enoxaparin adjusted for age and renal function, which was designed to minimize bleeding risk while maintaining the beneficial effects of enoxaparin. Based on the evidence from this trial, the 2007 ST-segment elevation myocardial infarction guidelines now preferentially recommend enoxaparin to be administered throughout the index hospitalization as per the dosing regimen used in ExTRACT-TIMI 25 in most patients treated with fibrinolytic therapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-008-0284-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "27"
      }
    ], 
    "name": "ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy", 
    "pagination": "1-10", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "44a23bf9e7c38ebb048ac2c78c27ef269f585d4c68715fb18614103fdd36921c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18931978"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-008-0284-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014406797"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-008-0284-0", 
      "https://app.dimensions.ai/details/publication/pub.1014406797"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000521.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-008-0284-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-008-0284-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-008-0284-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-008-0284-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-008-0284-0'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      21 PREDICATES      86 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-008-0284-0 schema:about N0110d1324878445bb8dfc7a0e1438b38
2 N01c4a884500e49b1b074600171180991
3 N13ce36144a094461ae41b01785096f89
4 N450842a4db54417fa93240137eef2644
5 N4e3e918d93b449c5872e2d0a0d5a848d
6 N631415ad591b44fc8a7d07b5e8c3fced
7 N6e69407c55594330b0f426300c32dba5
8 N8e1546e7644641a1ad20db5a01f7d3ea
9 N944db24841604300b1f685a46fa2b37a
10 N96ddddfae5e34ece9559bdaf3af13e9a
11 N9c8bc996447e4f948ba087aef2201c9b
12 Na851d7660bbc43318bcdef4d07a20d34
13 Na9511a7aa6e1445884d6fa2ed3f7b20e
14 Nab3274b1105547279a0c67b4f26ceafc
15 Nb166087ef39c4a48b072b33fc35cc15e
16 Nbe2a2223993f4ec496fce7d9b0567887
17 Nbfd1f71811d042a1852d0c3b2a84f2e4
18 Nc218dbbb653b4e3cba598709cda5327d
19 Ne41f96cbe3c047d18496f4dc43bb3250
20 Ne7627a2eb17a425d98efd938f706452a
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N7157f70f400549f4ae13adb9c1d75fa8
24 schema:citation sg:pub.10.1007/s00392-0591-z
25 https://doi.org/10.1016/j.ahj.2004.08.038
26 https://doi.org/10.1016/j.ahj.2006.06.036
27 https://doi.org/10.1016/j.ahj.2007.07.027
28 https://doi.org/10.1016/j.amjmed.2007.08.020
29 https://doi.org/10.1016/j.jacc.2004.05.045
30 https://doi.org/10.1016/j.jacc.2006.12.049
31 https://doi.org/10.1016/j.jacc.2007.01.092
32 https://doi.org/10.1016/j.jacc.2007.01.093
33 https://doi.org/10.1016/j.jacc.2007.10.001
34 https://doi.org/10.1016/s0140-6736(01)05775-0
35 https://doi.org/10.1016/s0140-6736(02)07588-8
36 https://doi.org/10.1016/s0140-6736(02)07595-5
37 https://doi.org/10.1016/s0735-1097(03)00163-3
38 https://doi.org/10.1016/s0735-1097(04)01110-6
39 https://doi.org/10.1053/euhj.2001.2940
40 https://doi.org/10.1056/nejmoa060898
41 https://doi.org/10.1093/eurheartj/ehm081
42 https://doi.org/10.1093/eurheartj/ehm179
43 https://doi.org/10.1093/eurheartj/ehm210
44 https://doi.org/10.1093/eurheartj/ehm224
45 https://doi.org/10.1159/000180580
46 https://doi.org/10.1161/01.cir.0000013402.34759.46
47 https://doi.org/10.1161/01.cir.0000050144.67910.13
48 https://doi.org/10.1161/01.cir.0000081659.72985.a8
49 https://doi.org/10.1161/01.cir.0000097559.09335.4a
50 https://doi.org/10.1161/01.cir.0000142047.28024.f2
51 https://doi.org/10.1161/01.cir.100.10.1134
52 https://doi.org/10.1161/01.cir.102.17.2031
53 https://doi.org/10.1161/01.cir.103.18.2310
54 https://doi.org/10.1161/circulationaha.105.551143
55 https://doi.org/10.1161/circulationaha.105.595397
56 https://doi.org/10.1161/circulationaha.106.179918
57 https://doi.org/10.1161/circulationaha.106.679548
58 https://doi.org/10.1161/circulationaha.107.182616
59 https://doi.org/10.1161/hc3101.093866
60 https://doi.org/10.7326/0003-4819-130-6-199903160-00002
61 schema:datePublished 2009-01
62 schema:datePublishedReg 2009-01-01
63 schema:description Unfractionated heparin (UFH) for 48 h has been the traditional standard anticoagulant with fibrinolytics. The Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction (ExTRACT)-Thrombolysis in Myocardial Infarction (TIMI) 25 trial prospectively studied the usefulness of enoxaparin and found that in patients treated with fibrinolysis, enoxaparin administered throughout the index hospitalization was superior to the standard 48-h UFH infusion. However, enoxaparin increased major bleeding. The data from this large trial were further analyzed across various subgroups and these results support the use of enoxaparin in a broad range of patients. The ExTRACT-TIMI 25 trial employed a novel dosing regimen for enoxaparin adjusted for age and renal function, which was designed to minimize bleeding risk while maintaining the beneficial effects of enoxaparin. Based on the evidence from this trial, the 2007 ST-segment elevation myocardial infarction guidelines now preferentially recommend enoxaparin to be administered throughout the index hospitalization as per the dosing regimen used in ExTRACT-TIMI 25 in most patients treated with fibrinolytic therapy.
64 schema:genre research_article
65 schema:inLanguage en
66 schema:isAccessibleForFree false
67 schema:isPartOf N37c91cf04b7541179eb763674bb40704
68 N5cc53a42e3b642e1861ef5820b3bc09e
69 sg:journal.1113719
70 schema:name ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy
71 schema:pagination 1-10
72 schema:productId N12ef7645607248ab9f7aa3b71e4797b8
73 N15c89a9305aa4d4fb61a04dd3e033817
74 N463280d7ff4c4ed0b33ae94be8f5339d
75 N8956f4b8e9b944cbab1e0ca589ed3063
76 Nddaf32e7629a4ff8813d85126bed9200
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014406797
78 https://doi.org/10.1007/s11239-008-0284-0
79 schema:sdDatePublished 2019-04-11T01:09
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher N822a3fd6e79c41aabf4eb3468416726b
82 schema:url http://link.springer.com/10.1007%2Fs11239-008-0284-0
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N0110d1324878445bb8dfc7a0e1438b38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Drug Therapy, Combination
88 rdf:type schema:DefinedTerm
89 N01c4a884500e49b1b074600171180991 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Combined Modality Therapy
91 rdf:type schema:DefinedTerm
92 N12ef7645607248ab9f7aa3b71e4797b8 schema:name nlm_unique_id
93 schema:value 9502018
94 rdf:type schema:PropertyValue
95 N13ce36144a094461ae41b01785096f89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Risk Assessment
97 rdf:type schema:DefinedTerm
98 N15c89a9305aa4d4fb61a04dd3e033817 schema:name dimensions_id
99 schema:value pub.1014406797
100 rdf:type schema:PropertyValue
101 N37c91cf04b7541179eb763674bb40704 schema:issueNumber 1
102 rdf:type schema:PublicationIssue
103 N450842a4db54417fa93240137eef2644 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Stroke
105 rdf:type schema:DefinedTerm
106 N463280d7ff4c4ed0b33ae94be8f5339d schema:name readcube_id
107 schema:value 44a23bf9e7c38ebb048ac2c78c27ef269f585d4c68715fb18614103fdd36921c
108 rdf:type schema:PropertyValue
109 N4e3e918d93b449c5872e2d0a0d5a848d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Enoxaparin
111 rdf:type schema:DefinedTerm
112 N5cc53a42e3b642e1861ef5820b3bc09e schema:volumeNumber 27
113 rdf:type schema:PublicationVolume
114 N631415ad591b44fc8a7d07b5e8c3fced schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Middle Aged
116 rdf:type schema:DefinedTerm
117 N6e69407c55594330b0f426300c32dba5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N7157f70f400549f4ae13adb9c1d75fa8 rdf:first sg:person.0650361070.35
121 rdf:rest Na5fc724941d244f5af05941c881235ce
122 N822a3fd6e79c41aabf4eb3468416726b schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 N8956f4b8e9b944cbab1e0ca589ed3063 schema:name doi
125 schema:value 10.1007/s11239-008-0284-0
126 rdf:type schema:PropertyValue
127 N8e1546e7644641a1ad20db5a01f7d3ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Recurrence
129 rdf:type schema:DefinedTerm
130 N944db24841604300b1f685a46fa2b37a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Aged
132 rdf:type schema:DefinedTerm
133 N96ddddfae5e34ece9559bdaf3af13e9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Anticoagulants
135 rdf:type schema:DefinedTerm
136 N9c8bc996447e4f948ba087aef2201c9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Male
138 rdf:type schema:DefinedTerm
139 Na5fc724941d244f5af05941c881235ce rdf:first sg:person.0702207604.00
140 rdf:rest rdf:nil
141 Na851d7660bbc43318bcdef4d07a20d34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Randomized Controlled Trials as Topic
143 rdf:type schema:DefinedTerm
144 Na9511a7aa6e1445884d6fa2ed3f7b20e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Female
146 rdf:type schema:DefinedTerm
147 Nab3274b1105547279a0c67b4f26ceafc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Comorbidity
149 rdf:type schema:DefinedTerm
150 Nb166087ef39c4a48b072b33fc35cc15e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Heparin
152 rdf:type schema:DefinedTerm
153 Nbe2a2223993f4ec496fce7d9b0567887 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Myocardial Infarction
155 rdf:type schema:DefinedTerm
156 Nbfd1f71811d042a1852d0c3b2a84f2e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Fibrinolytic Agents
158 rdf:type schema:DefinedTerm
159 Nc218dbbb653b4e3cba598709cda5327d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Thrombolytic Therapy
161 rdf:type schema:DefinedTerm
162 Nddaf32e7629a4ff8813d85126bed9200 schema:name pubmed_id
163 schema:value 18931978
164 rdf:type schema:PropertyValue
165 Ne41f96cbe3c047d18496f4dc43bb3250 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Ticlopidine
167 rdf:type schema:DefinedTerm
168 Ne7627a2eb17a425d98efd938f706452a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Disease-Free Survival
170 rdf:type schema:DefinedTerm
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
175 schema:name Clinical Sciences
176 rdf:type schema:DefinedTerm
177 sg:journal.1113719 schema:issn 0929-5305
178 1573-742X
179 schema:name Journal of Thrombosis and Thrombolysis
180 rdf:type schema:Periodical
181 sg:person.0650361070.35 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
182 schema:familyName Thomas
183 schema:givenName Deepak
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650361070.35
185 rdf:type schema:Person
186 sg:person.0702207604.00 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
187 schema:familyName Giugliano
188 schema:givenName Robert P.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702207604.00
190 rdf:type schema:Person
191 sg:pub.10.1007/s00392-0591-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1045412171
192 https://doi.org/10.1007/s00392-0591-z
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.ahj.2004.08.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009758285
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.ahj.2006.06.036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019296115
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.ahj.2007.07.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017729419
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.amjmed.2007.08.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010042911
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.jacc.2004.05.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049874485
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.jacc.2006.12.049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005322302
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.jacc.2007.01.092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035723507
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/j.jacc.2007.01.093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033029785
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/j.jacc.2007.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000412980
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/s0140-6736(01)05775-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025610328
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/s0140-6736(02)07588-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029951364
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/s0140-6736(02)07595-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051789238
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/s0735-1097(03)00163-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022620585
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/s0735-1097(04)01110-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054657813
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1053/euhj.2001.2940 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057075086
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1056/nejmoa060898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020761305
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1093/eurheartj/ehm081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028799784
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1093/eurheartj/ehm179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045265604
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1093/eurheartj/ehm210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000964266
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1093/eurheartj/ehm224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004392967
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1159/000180580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051087304
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1161/01.cir.0000013402.34759.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005846812
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1161/01.cir.0000050144.67910.13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013388391
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1161/01.cir.0000081659.72985.a8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011377809
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1161/01.cir.0000097559.09335.4a schema:sameAs https://app.dimensions.ai/details/publication/pub.1011300096
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1161/01.cir.0000142047.28024.f2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015585450
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1161/01.cir.100.10.1134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041879155
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1161/01.cir.102.17.2031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020744727
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1161/01.cir.103.18.2310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040443584
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1161/circulationaha.105.551143 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010580667
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1161/circulationaha.105.595397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010410408
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1161/circulationaha.106.179918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000630307
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1161/circulationaha.106.679548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027489511
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1161/circulationaha.107.182616 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035207018
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1161/hc3101.093866 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040424701
263 rdf:type schema:CreativeWork
264 https://doi.org/10.7326/0003-4819-130-6-199903160-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073703194
265 rdf:type schema:CreativeWork
266 https://www.grid.ac/institutes/grid.62560.37 schema:alternateName Brigham and Women's Hospital
267 schema:name Department of Nuclear Cardiology, Brigham and Women’s Hospital, 75 Francis Street, 02115, Boston, MA, USA
268 TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis Street, 02115, Boston, MA, USA
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...